The Hemodialys And Peritoneal Dialysis Market is expected to grow at a 6.1% CAGR between 2022 and 2032.
The market for hemodialysis and peritoneal dialysis is expected to grow from $81.8 billion in 2022 to US$ 148.1 billion in 2032. Previously, the market grew at a 6.4% CAGR (2015-2021), resulting in a market size of US$ 76.9 billion in 2021.
To learn more about this report @ https://www.futuremarketinsights.com/reports/hemodialys-and-peritoneal-dialysis-market
The rising number of ESRD patients, the rising commonness of diabetes and hypertension, the shortage of organ benefactors and the dangers related with transfers, mechanical headways, and drives by hemodialys and peritoneal dialysis market pioneers to present high level items and administrations are driving development in this hemodialys and peritoneal dialysis market.
Be that as it may, the risks and troubles associated with dialysis, as well as item reviews, are expected to restrict the hemodialys and peritoneal dialysis market’s improvement somewhat. The Covid pandemic is presently representing various issues to clinical medical care professionals and patients around the world
KEY TAKEAWAYS:
- In the type sector, Hemodialys from the Hemodialys and peritoneal dialysis market are anticipated to flourish at the quickest CAGR of 5.5% through 2032.
- With a CAGR of 5.7% through 2032, Hospital Dialysis are predicted to grow significantly in the application sector of the Hemodialys and peritoneal dialysis market.
- The market size for Hemodialys and peritoneal dialysis market in the United States is expected to reach US$ 49.4 Billion by 2032, growing at a CAGR of 6% during the research period.
- China is anticipated to reach a market size of US$ 10.2 billion in Hemodialys and peritoneal dialysis by 2032, with a CAGR of 5.5% during the forecast period.
- By 2032, South Korea is expected to reach a market size of US$ 5.3 Billion in Hemodialys and peritoneal dialysis, with a CAGR of 49% during the forecast period.
COMPETITIVE LANDSCAPE:
The major players in the global hemodialys and peritoneal dialysis market are Fresenius Medical Care AG Co. KGaA (Germany), Baxter International, Inc. (US), Nikkiso Co., Ltd. (Japan), B. Braun Melsungen AG (Germany), Asahi Kasei Corporation (Japan), DaVita Inc. (US), Nipro Corporation (Japan), Cantel Medical Corporation (US), Diaver (US).
RECENT DEVELOPMENT:
Mar Cor (Cantel Medical Corporation) announced the release of their unique EON Portable Hemodialys Water System in 2021.
Fresenius Medical Care AG Co. KGaA announced the release of a PVC-free peritoneal dialysis solution bag for home dialysis therapy in 2020.
Baxter International Inc. gained FDA clearance for a De Novo application for Theranova dilayzers designed to provide enhanced hemodialys (HDx) treatment in 2020.
